Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
European Urology Open Science|April 30, 2026
Treatment Persistence and Adherence with Overactive Bladder Medications in Taiwan: A Retrospective Database AnalysisShiau-Han Chen, Chung-Yu Chen, Farid Abdul Hadi
European Urology Open Science|November 17, 2025
Efficacy and Safety of Mirabegron in Males with Overactive Bladder and Lower Urinary Tract Symptoms: Analysis from an Integrated DatabaseFarid Abdul Hadi, Arianne Schild, Merete Kock Hansen, et al.
Menopause (New York, N.Y.)|March 24, 2026
Targeted literature review of concepts related to women's experiences and perceptions of vasomotor symptoms associated with menopauseDaniel Bin Ng, Somali Misra Burgess, Ching-Chou Tsai, et al.
Neurourology and Urodynamics|January 31, 2024
Safety and efficacy of an α1 -blocker plus mirabegron compared with an α1 -blocker plus antimuscarinic in men with lower urinary tract symptoms secondary to benign prostatic hyperplasia and overactive bladder: A systematic review and network meta-analysisSender Herschorn, Tufan Tarcan, Yuan-Hong Jiang, et al.
International Neurourology Journal|October 13, 2025
A Retrospective Database Analysis of Anticholinergic Burden Among Older Patients With and Without Overactive Bladder in South KoreaKyu-Sung Lee, Juhee Cho, Danbee Kang, et al.
ESC Heart Failure|October 25, 2016
Rationale and design of a pilot randomized controlled trial to assess the role of intravenous ferric carboxymaltose in Asian patients with heart failure (PRACTICE-ASIA-HF)Tee Joo Yeo, Poh Shuan Daniel Yeo, Farid Abdul Hadi, et al.
Climacteric : the Journal of the International Menopause Society|February 11, 2026
Treatment patterns of hormone therapy for menopause-associated vasomotor symptoms: analysis of the HIRA database in South KoreaJung-Ho Shin, Geum Joon Cho, Farid Abdul Hadi, et al.
Asian Journal of Urology|February 24, 2025
An open-label, randomized, post-authorization study of mirabegron in Chinese participants with overactive bladderZhipeng Zhang, Deyi Luo, Zhong Chen, et al.
ESC Heart Failure|January 19, 2018
Single-dose intravenous iron in Southeast Asian heart failure patients: A pilot randomized placebo-controlled study (PRACTICE-ASIA-HF)Tee Joo Yeo, Poh Shuan Daniel Yeo, Farid Abdul Hadi, et al.
Pageof 1